Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01022736Phase 4Completed
Phase 4, open-label, single-arm trial of gabapentin in postoperative pain, sponsored by Queen's University. Primary endpoint: Plasma concentrations of gabapentin. Started May 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01022736.